Male infertility is a complicated problem that often poses a challenge to couples
trying to conceive. Its causes may be very diverse and may result from genetic or
environmental factors such as excess stress, obesity, and smoking. Moreover,
infertility may be caused by structural changes or abnormalities in the
functioning of the endocrine system. Biomarkers, genetic tests, and AI can all be
used to improve semen analysis to help doctors make better evaluations and
ensure that each patient gets the best care. This research talks about drug,
surgery, and assisted reproductive technology treatments for male infertility
problems. Medicines fix hormonal abnormalities and microelement deficiency.
More invasive procedures such as TESA, PESA, TESE, and MESA can help with
obstructive azoospermia. Doctors can cure structural problems with surgical
techniques, such as varicocelectomy and vasovasostomy, including effect
removal from past vasectomies. Men facing difficulties with conception can
explore fertility options like in vitro fertilization (IVF), intrauterine ultrasonic
(IUI), and intracytoplasmic sperm injection (ICSI) when other family planning
approaches fail. The medical background of the patient, the cause of their
infertility, and their intended results define most of the degree of efficacy of the
treatment. Further research is required to consider the ethical and social
consequences and possible applications of artificial intelligence in reproductive
medicine. A thorough, patient-centered approach helps couples trying to
conceive and those dealing with male infertility benefit from therapy.
Keywords: Male infertility, hormonal imbalance, reproductive health, sperm
retrieval techniques